Metraipolis › archive › dc_10cfd3d4fb8f

Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial — Europe PMC PMID:41290616

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41290616
DOI
10.1038/s41392-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-08T06:03:44.415Z
SHA-256 of the archived text
601853a51fc68af3eedca3c3ffc179cb98974bce32ce87f8c9ca4607c3228ad3
Stable URL of this page
https://metraipolis.com/documento/dc_10cfd3d4fb8f

How to cite

Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial — Europe PMC PMID:41290616 — Europe PMC (en), https://europepmc.org/article/MED/41290616 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_10cfd3d4fb8f (Metraipolis archive dc_10cfd3d4fb8f, sha256 601853a51fc68af3eedca3c3ffc179cb98974bce32ce87f8c9ca4607c3228ad3)
BibTeX
@misc{dc10cfd3d4fb8f,
  title = {Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial — Europe PMC PMID:41290616},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41290616},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_10cfd3d4fb8f; sha256 601853a51fc68af3eedca3c3ffc179cb98974bce32ce87f8c9ca4607c3228ad3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41290616. Agents can read the archived copy with the MCP tool read_document.